Compugen reported -8429000 in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Clal Biotechnology ILS -5295000 2.09M Dec/2022
Compugen -8429000 946K Jun/2025
Life Technologies USD -259000 15.39M Jun/2025
RedHill Biopharma USD 2.69M 108.46M Jun/2023